NCT03793920

Brief Summary

Hypothesis: Individuals presenting with prenatal alcohol exposure (PEA) show emotional abilities deficits, and imbalance between the two systems involved in decision-making according to dual-process models, namely an under-activated reflective system (involved in deliberate behaviors) and an over-activated affective-automatic one (involved in impulsive behaviors). Primary objective: To explore performance (as a percentage of correct answers) in an emotional facial expression decoding task in PEA participants compared to controls without alcohol disorder.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 18, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 4, 2019

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2022

Completed
Last Updated

October 3, 2022

Status Verified

September 1, 2022

Enrollment Period

4 years

First QC Date

December 18, 2018

Last Update Submit

September 30, 2022

Conditions

Keywords

Prenatal alcohol exposureEmotionalCognitionAddictionFetal Alcohol Syndrome

Outcome Measures

Primary Outcomes (1)

  • Percentage of correct answers of an emotional facial expression (EFE)

    Performance of an emotional facial expression (EFE) decoding task in EPA subjects and compare it to non-alcohol dependent controls

    one day

Secondary Outcomes (5)

  • Psychopathological assessment by Mini International Neuropsychiatric Interview MINI

    one day

  • Percentage of correct answers ant latency of behavioral answers

    one day

  • State-Trait-Anxiety Inventory (STAI) score

    one day

  • Beck Depression Inventory score

    one day

  • Toronto Alexithymia Scale TAS-20 score

    one day

Study Arms (4)

PEA patients without alcohol disorder

EXPERIMENTAL

A group of 36 PEA patient without alcohol-dependence (AD), performing 6 behavioral tasks.

Other: Facial Emotion Test

PEA patients with alcohol disorder

SHAM COMPARATOR

A group of 36 PEA participants, currently alcohol-dependent, performing 6 behavioral tasks.

Other: Facial Emotion Test

Healthy controls with AD father

SHAM COMPARATOR

A group of 36 non-alcohol-dependent controls whose father was alcohol-dependent during their childhood and adolescence, performing 6 behavioral tasks.

Other: Facial Emotion Test

Healthy controls without AD father

SHAM COMPARATOR

A group of 36 non-alcohol-dependent controls whose father was not alcohol-dependent during their childhood and adolescence, performing 6 behavioral tasks.

Other: Facial Emotion Test

Interventions

All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.

Healthy controls with AD fatherHealthy controls without AD fatherPEA patients with alcohol disorderPEA patients without alcohol disorder

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Man or woman aged between 18 and 60 years
  • Able to understand and to speak French
  • Able to understand Note of information and to sign consent form
  • Available health insurance
  • Normal (or corrected to normal) vision and audition
  • For women: Negative pregnancy test or menopausal for at least one year
  • For Group 1 only : PEA criteria and no alcohol consumption within the three days preceding the experiment.
  • For Group 2 only : PEA criteria, diagnosed with severe alcohol addiction and currently abstinent (for at least 15 days).
  • For Group 3 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment and father diagnosed with severe alcohol addiction.
  • For Group 4 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment.

You may not qualify if:

  • Refusal of participation after clear and fair information on the study.
  • Visual or auditory sensory disability to participate in the study.
  • Benzodiazepines and / or Antipsychotic concomitant treatment.
  • History of (or current) neurologic disease
  • History of (or current) psychiatric disorder (apart alcohol-dependence for the PEA-alcohol-dependent group)
  • Psychoactive Substance Use or Abuse other than tobacco and alcohol.
  • Pregnant or breast-feeding women.
  • Underage (\<18 yo) or adults under guardianship, judicial protection, or deprived of liberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CSAPA

Lille, 59037, France

Location

CHRU Lille, Fontan2

Lille, France

Location

MeSH Terms

Conditions

Behavior, AddictiveFetal Alcohol Spectrum Disorders

Condition Hierarchy (Ancestors)

Compulsive BehaviorImpulsive BehaviorBehaviorFetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAlcohol-Induced DisordersAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced Disorders

Study Officials

  • Olivier COTTENCIN, MD, PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2018

First Posted

January 4, 2019

Study Start

November 8, 2018

Primary Completion

November 11, 2022

Study Completion

November 11, 2022

Last Updated

October 3, 2022

Record last verified: 2022-09

Locations